Literature DB >> 1606976

Transurethral resection syndrome. A prospective study.

C M Goel1, D F Badenoch, C G Fowler, J P Blandy, R C Tiptaft.   

Abstract

Significant hyponatraemia has been reported following transurethral prostatectomy (TURP) in 11-41% of cases. The majority of previous studies have been performed retrospectively. A prospective study was undertaken of 100 patients undergoing TURP. In all, a 24-Charr sheath with non-irrigating, resectoscope and 1.5% glycine as irrigant was used. Volume of irrigant used, weight of prostate and length of procedure were recorded. Serum electrolytes were measured at anaesthetic induction and immediately on transfer to the recovery room. In none of the 100 patients was there a statistically significant fall in serum sodium following resection. No clinical changes of transurethral resection (TUR) syndrome occurred. This study confirms that TUR syndrome and a significant fall in serum sodium can be virtually prevented in TURP and the use of an irrigating resectoscope or a trocar in the average case is not necessary.

Entities:  

Mesh:

Year:  1992        PMID: 1606976     DOI: 10.1159/000474792

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  3 in total

1.  The selection of the regional anaesthesia in the transurethral resection of the prostate (TURP) operation.

Authors:  S Ozmen; A Koşar; S Soyupek; A Armağan; M B Hoşcan; C Aydin
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

2.  Technique and results of interstitial laser coagulation.

Authors:  R Muschter; A Hofstetter
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

3.  A clinical study comparing BIVAP saline vaporization of the prostate with bipolar TURP in patients with prostate volume 30 to 80 mL: Early complications, physiological changes and postoperative follow-up outcomes.

Authors:  Ozgu Aydogdu; Ayhan Karakose; Yusuf Ziya Atesci
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.